OncoDNA

OncoDNA

Company specialized in precision medicine for the treatment of cancer.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
EBITDA(3.3m)(2.8m)(2.0m)(4.6m)(4.0m)(4.9m)-
Profit(3.7m)(3.3m)(3.1m)(5.4m)(5.3m)(6.1m)(10.4m)
  • Edit
DateInvestorsAmountRound
-

N/A

-

€7.7m

Series A

$20.6m

Series B
*
N/A

$7.1m

Valuation: $103m

-18.9x EV/LTM EBITDA

Series C
Total Funding€32.9m

Recent News about OncoDNA

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.